NRG-LU002: Randomized phase II/III trial of maintenance systemic therapy versus local consolidative therapy (LCT) plus maintenance systemic therapy for limited metastatic non-small cell lung cancer ...
A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I.
Multi-die assemblies greatly increase the number of things that can go wrong, and the difficulty of finding them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results